Skip to main content
. 2010 Mar 1;181(12):1285–1293. doi: 10.1164/rccm.200909-1331PP

Figure 1.

Figure 1.

Kaplan-Meier analysis showing survival in patients with systemic sclerosis–related pulmonary arterial hypertension (SSc-PAH) and idiopathic pulmonary arterial hypertension (IPAH) treated with prostanoids (6) or advanced therapy (4). ERA = endothelin receptor antagonists; mPAP = mean pulmonary arterial pressure; NYHA = New York Heart Association; PDE5 = phosphodiesterase 5; PVR = pulmonary vascular resistance.